HUBRO THERAPEUTICS AS

Closed at August 8th, 2026, Insolvency proceedings

Liquidation estate:

Utvikling og salg av biomedisinske produkter og tjenester. Formålet kan fremmes ved deltakelse i eller samarbeid med andre foretak i inn- og utland.

Forskning og utvikling av legemidler for behandling av kreft.

Organization

CEO: ØK
Øyvind Kongstun Arnesen1957
Chairman of the board: ØK
Øyvind Kongstun Arnesen1957
Operation time: 8 years; - Dec 5, 2018 to Aug 8, 2026
Type: Limited company
VAT registered: No
Number of employees: 0

Financials

Annual total result 2022: -31,551,681; NOK
Total equity 2022: 36,467,975; NOK

Last update: Dec 12, 2025

Management

Management / administration

Name	Role	Shares
ØK Øyvind Kongstun Arnesen 1957 Resigned	Managing Director/CEO	-

Board

Name	Role	Shares
ØK Øyvind Kongstun Arnesen 1957 Resigned	Chairman	-
KL Kjeld-Håkon Langeland Nilsen 1972	Board Member	-
AP Aitana Peire Morais 1977 Resigned	Board Member	-
BG Birgitte Gangmark Villmo 1985 Resigned	Board Member	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-
A AMESTO ACCOUNTHOUSE AS	Accountant	-

Last update: Mar 2, 2024

Ownership

No available data

Financials

in NOK

Summary

Year	2022	2021
Total operating income	0	53,550
Annual Total Result	-31,551,681	-7,536,854
Total assets	83,591,652	71,599,935
Total liabilities	47,123,677	3,580,279
Total equity	36,467,975	68,019,656

P&L

Year	2022	2021
Total operating income	0	53,550
Total operating costs	31,712,751	7,704,941
Operating result	-31,712,751	-7,651,391
Financial income/costs	161,070	114,537
Profit before tax	-31,551,681	-7,536,854
Total tax & extraordinary income/cost	0	0
Annual Total Result	-31,551,681	-7,536,854

Balance overview

Year	2022	2021
Total fixed assets	10,070,146	0
Total current assets	73,521,506	71,599,935
Total assets	83,591,652	71,599,935
Short term debt	11,698,677	3,580,279
Long term debt	35,425,000	0
Total liabilities	47,123,677	3,580,279
Contributed capital	36,467,975	68,019,656
Retained earnings	0	0
Total equity	36,467,975	68,019,656
Total equity and liabilities	83,591,652	71,599,935

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

HUBRO THERAPEUTICS AS921 833 016